By extending the time frame to sign up for COBRA coverage, people have at least 120 days to decide whether they want to elect COBRA, and possibly longer depending on when they lost their jobs.
Top Republican lawmakers are asking Oregon Gov. Kate Brown to reconsider her decision to tether Clackamas County to Multnomah and Washington counties as the state eases COVID-19 restrictions in the midst of the pandemic.
Scientists say they see steady progress and are expressing cautious optimism that a vaccine could be ready by spring.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Former Gov. John Kitzhaber, health care executives and government officials agreed during a panel that the state and industry need to do more than cut programs.
One of the most popular features of the Affordable Care Act is its guarantee of insurance coverage — at no greater cost — for people with preexisting health conditions.
California is the only state on the West Coast that is loosening rules so that families can visit their loved ones who are in care.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The Oregon Health Authority plans to delay a program that's projected to keep 300 children out of psychiatric residential treatment in its first year, saving the state money in the long term and keeping families together.
Coronavirus infections have spiked since Oregon began reopening its economy on May 15, and new state modeling of infection rates and hospitalizations released Friday predicts the pandemic could spread dramatically by the end of July.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Oregon health care companies joined the throng of small businesses nationwide securing money from the federal Payroll Protection Program, newly released data show.
Given the prevailing business-centric model of American drug pricing, a COVID-19 vaccine could be budget breaking, perhaps making it unavailable to many.
